หน้าแรก
ค้นหา
Neelima Denduluri, MD -- Treatment of Triple Negative Breast Cancer
Neelima Denduluri, MD Treatment of Triple Negative Breast Cancer Oncology Outlook 2018 USA MCI
แสดงข้อมูลเพิ่มเติม 1
Neelima Denduluri, MD -- Treatment of Triple Negative Breast Cancer
Neelima Denduluri, MD, discusses exciting new approaches to treating breast cancer
Neelima Denduluri, MD, tells us about the recent updates to breast cancer guidelines
Neelima Denduluri, MD, discusses outcomes from the ImPassion130 trial
Neelima Denduluri, MD, considers whether the results of TAILORx are practice-changing
Neelima Denduluri, MD, regarding the EMBRACA trial in HER2- metastatic breast cancer
Neelima Denduluri, MD, regarding the MONALEESA-7 trial in premenopausal metastatic breast cancer
Neelima Denduluri, MD, comments on the role of CDK4/6 inhibitors
Dr. Denduluri on the Role of Neoadjuvant Therapy in HER2+ Breast Cancer
Dr. Yee on Neoadjuvant Therapy for Triple-Negative Breast Cancer
Neelima Denduluri, MD, discusses the results of the MONARCH-2 study presented at ASCO
Neelima Denduluri, MD, on the MONALEESA-3 study in HR+/HER2- advanced breast cancer
Dr. Bardia on Sacituzumab Govitecan in Triple-Negative Breast Cancer
Neelima Denduluri, MD, offers opinion on the PERSEPHONE trial in early HER2+ breast cancer
Management of Triple-negative Breast Cancer
Dr. Neelima Denduluri on WUSA 9
Dr. Carey on Tailoring Treatment in Triple-Negative Breast Cancer
Dr. Denduluri on Treatment Approaches in Early-Stage HR+/HER2- Breast Cancer
Clinical Approach to Triple-Negative Breast Cancer
FREE Webinar: Treatment Options for Triple-Negative Breast Cancer presented by Dr. Edith Mitchell